Hegedus used SELDI-TOF-MS to analyze proteomes of pediatric leukemia cell lines, including ALL, mixed lineage leukemia (MLL) and acute myeloid leukemia (AML) cell lines, and pediatric leukemia bone marrow samples of different subtypes. This evidence concerns the gene KMT2A and acute myeloid leukemia.